![Cui Ping Gu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cui Ping Gu
Directeur/Membre du Conseil chez Cullgen, Inc.
Profil
Cui Ping Gu is currently a Director at Cullgen, Inc. and a Non-Executive Director at QuantumPharm, Inc. She previously worked as a Project Manager at Eli Lilly & Co. Dr. Gu holds a doctorate degree from Shanghai Jiao Tong University, which she obtained in 2007.
She also has an undergraduate degree from Shanghai Jiao Tong University, which she received in 2002.
Postes actifs de Cui Ping Gu
Sociétés | Poste | Début |
---|---|---|
Cullgen, Inc.
![]() Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
QuantumPharm, Inc.
![]() QuantumPharm, Inc. BiotechnologyHealth Technology QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China. | Directeur/Membre du Conseil | 05/09/2018 |
Anciens postes connus de Cui Ping Gu
Sociétés | Poste | Fin |
---|
Formation de Cui Ping Gu
Shanghai Jiao Tong University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
![]() | Health Technology |
Entreprise privées | 1 |
---|---|
Cullgen, Inc.
![]() Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Health Technology |